[1] |
Ballestri S,Lonardo A,Bonapace S,et al.Risk of cardiovascular,cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease[J].World J Gastroenterol,2014,20(7):1724-1745.
|
[2] |
Oni ET,Agatston AS,Blaha MJ,et al.A systematic review:burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver;should we care?[J].Atherosclerosis,2013,230(2):258-267.
|
[3] |
赵晓云,陈伟华,路永刚,等. 河北省33843机关职员非酒精性脂肪肝患病率及其危险因素[J]. 中国老年学杂志,2013,33(20):5079-5081.
|
[4] |
范建高,朱军,李新建,等.上海市成人非酒精性脂肪肝患病率及其危险因素流行病学调查[J].中华肝脏病杂志,2005,13(2):83-88.
|
[5] |
Kohjima M,Enjoji M,Higuchi N,et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease[J]. Int J Mol Med,2007,20(3):351-358.
|
[6] |
Li S,Chen X,Zhang H,et al.Differential expression of microRNAs in mouse liver under aberrant energy metabolic status[J].J Lipid Res,2009,50(9):1756-1765.
|
[7] |
Cheung O,Puri P,Eicken C,et al.Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expre-ssion[J]. Hepatology,2008,48(6):1810-1820.
|
[8] |
Jin X,Ye YF,Chen SH,et al.MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease[J]. Dig Liver Dis,2009,41(4):289-297.
|
[9] |
Pogribny IP,Starlard-Davenport A,Tryndyak VP,et al.Difference in expression of hepatic microRNAs miR-29c,miR-34a,miR-155,and miR-200b is associated with strain-specifi susceptibility to dietary nonalcoholic steatohepatitis in mice[J]. Lab Invest,2010,90(10):1437-1446.
|
[10] |
Ahn J,Lee H,Jung CH,et al.Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet[J]. Mol Nutr Food Res,2012,56(11):1665-1674.
|
[11] |
Sun C,Huang F,Liu X,et al. miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR[J].Int J Mol Med,2015,35(3):847-853.
|
[12] |
Yamada H,Suzuki K,Ichino N,et al. Associations between circulating microRNAs (miR-21,miR-34a,miR-122 and miR-451) and non-alcoholic fatty liver[J].Clinica Chimica Acta,2013,424:99-103.
|
[13] |
Cermelli S,Ruggieri A,Marrero JA,et al.Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease[J]. PLoS One,2011,6(8):1-8.
|
[14] |
Kida K,Nakajima M,Mohri T,et al. PPARα is regulated by miR-21 and miR-27b in human liver[J]. Pharm Res,2011,28(10):2467-2476.
|
[15] |
Marquez RT,Wendlandt E,Galle CS,et al. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration,targets Pellino-1,and inhibits NF-kappaB signaling[J].Am J Physiol Gastrointest Liver Physiol,2010,298(4):G535-G541.
|
[16] |
Seeger T,Fischer A,Muhly-Reinholz M,et al.Long-term inhibition of miR-21 leads to reduction of obesity in db/db mice[J].Obesity,2014,22(11):2352-2360.
|